Switching from Risperidone to Lurasidone for Bipolar 2 with Psychotic Symptoms

Rationale for Medication Switch

• When a patient has been on an adequate dose of an antipsychotic for at least 4 weeks without significant improvement in symptoms, guidelines recommend switching to an alternative antipsychotic with a different pharmacodynamic profile 1, 2
• The lack of response to risperidone after a month of treatment at a therapeutic dose indicates the need for a medication change 2, 3
• Switching strategies should involve gradual cross-titration informed by the half-life and receptor profiles of each medication 2

Implementation of the Switch

• Consider a gradual cross-titration approach, slowly decreasing risperidone while introducing lurasidone 2
• Monitor closely during the transition period for any worsening of symptoms or emergence of side effects 2
• Assess response to lurasidone after 4-6 weeks at an adequate dose before determining efficacy 2

Important Considerations and Caveats

• If psychotic symptoms remain significant after an adequate trial of lurasidone, reassessment of diagnosis and potential contributing factors should be undertaken 3
• If bipolar depression with psychosis is confirmed and two antipsychotic trials have failed, consider clozapine as the next step, particularly if psychotic symptoms are prominent 2, 3

Monitoring Recommendations

• Assess treatment effectiveness early and regularly during the switch process 1